Free Trial

Oncolytics Biotech (ONC) Insider Trading & Ownership

Oncolytics Biotech logo
C$14.90 -0.20 (-1.32%)
As of 09/3/2025

Oncolytics Biotech (TSE:ONC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.82%
Number Of
Insiders Buying
(Last 12 Months)
10
Amount Of
Insider Buying
(Last 12 Months)
C$513.95K
Number Of
Insiders Selling
(Last 12 Months)
0
Get ONC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oncolytics Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ONC Insider Buying and Selling by Quarter

Oncolytics Biotech Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/12/2026
Allison Hagerman
Insider
Buy10,000C$1.14C$11,400.00
2/12/2026
Bernd Robert Seizinger
Director
Buy40,000C$1.17C$46,800.00
2/12/2026
Deborah Brown
Director
Buy25,000C$1.17C$29,250.00
2/12/2026
Jared Ryan Kelly
Insider
Buy29,500C$1.16C$34,220.00
2/12/2026
Kirk Look
Insider
Buy12,000C$1.16C$13,920.00
2/12/2026
Patricia Andrews
Director
Buy35,400C$1.18C$41,772.00
2/12/2026
Thomas Heineman
Insider
Buy12,132C$1.14C$13,830.48
2/12/2026
Wayne Pisano
Director
Buy30,000C$1.16C$34,800.00
2/11/2026
Andrew P Aromando
Insider
Buy29,600C$1.18C$34,928.00
2/11/2026
Bernd Robert Seizinger
Director
Buy60,000C$1.14C$68,400.00
2/11/2026
Jared Ryan Kelly
Insider
Buy5,600C$1.15C$6,440.00
7/17/2025
Allison Hagerman
Senior Officer
Buy4,600C$1.71C$7,866.00
7/17/2025
Thomas Heineman
Senior Officer
Buy15,000C$1.74C$26,098.50
7/16/2025
Jared Ryan Kelly
Senior Officer
Buy50,400C$1.63C$82,284.50
7/15/2025
Andrew P. Aromando
Senior Officer
Buy25,500C$1.62C$41,425.92
7/15/2025
Kirk Look
Senior Officer
Buy12,800C$1.60C$20,517.12
(Data available from 1/1/2013 forward)

ONC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Oncolytics Biotech includes Allison Hagerman, Andrew P Aromando, Bernd Robert Seizinger, Deborah Brown, Jared Ryan Kelly, Kirk Look, Patricia Andrews, Thomas Heineman, and Wayne Pisano. Learn more on insiders at ONC.

3.82% of Oncolytics Biotech stock is owned by insiders. Learn more on ONC's insider holdings.

The following insiders have purchased ONC shares in the last 24 months: Allison Hagerman (C$19,266.00), Andrew P Aromando (C$34,928.00), Bernd Robert Seizinger (C$115,200.00), Deborah Brown (C$29,250.00), Jared Ryan Kelly (C$122,944.50), Kirk Look (C$34,437.12), Patricia Andrews (C$41,772.00), Thomas Heineman (C$39,928.98), and Wayne Pisano (C$34,800.00).

Insiders have purchased a total of 397,532 ONC shares in the last 24 months for a total of C$513,952.52 bought.



This page (TSE:ONC) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners